N-methyl-1-(3-methyl-1,2,4-oxadiazol-5-yl)methanamine, 95.0%, 5g

1,3,5-Trifluoro-2,4-dinitrobenzene, 97.0%, 25g

1,3,8-Trihydroxy-6-methyl-anthraquinone, 95.0%, 25g

N-(Allyloxy)-2-nitrobenzenesulfonamide, 95.0%, 100g

5-BROMO-4,4,5,5-TETRAFLUOROPENTANOIC ACID, 95.0%, 250mg

Trimethylsilyl Difluoro(fluorosulfonyl)acetate>96.0%(GC)5g

5'-(4-Carboxy-3-hydroxyphenyl)-3,3''-dihydroxy-[1,1':3',1''-terphenyl]-4,4''-dicarboxylic acid, 97%, 1g

3-Bromo-6-(trifluoromethyl)pyridin-2-amine, 95.0%, 25g

HPLC column NUCLEODUR® NH2-RP 5 µm, 250 mm, 4 mm, 1 Piece(s)

4-Bromobenzylmethylsulfone, 97.0%, 1g

(R)-tert-Butyl 2-amino-3-(3-bromophenyl)propanoate hydrochloride, 97.0%, 1g

9-Phenanthreneboronic acid, 95.0%, 1g

2-Bromo-1,7-naphthyridine, 95.0%, 1g